Company News

RB Buys India’s Paras Pharmaceuticals Ltd

Portfolio features variety of heath and personal care.

Author Image

By: TOM BRANNA

Editor

Reckitt Benckiser Group (RB) has agreed to buy Paras Pharmaceuticals Limited (Paras) for INR 32.6 billion (Indian Rupees) (approximately GBP 460 million) from the current shareholders, including the Patel family and Actis, the emerging markets private equity investor. RB will finance the transaction from existing facilities. Paras is a privately-owned Indian company with a portfolio of leading Indian over the counter Health and Personal Care brands including: * Moov, the No 2 topical analg...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters